Actively Recruiting
Burst Spinal Cord Stimulation for Chronic Radicular Pain After Lumbar Spine Surgery A Randomized Double-Blind Sham-Controlled Crossover Trial
Led by St. Olavs Hospital · Updated on 2024-12-24
50
Participants Needed
1
Research Sites
223 weeks
Total Duration
On this page
Sponsors
S
St. Olavs Hospital
Lead Sponsor
N
Norwegian University of Science and Technology
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying the use of spinal cord stimulation (SCS) to treat chronic radicular pain that persists after lumbar spine surgery. This pain is neuropathic and difficult to manage with non-surgical treatments. Traditional SCS works by replacing pain sensations with a tingling feeling called paresthesia, which some patients find uncomfortable. A newer approach called "burst" SCS delivers high-frequency electrical stimuli without causing paresthesia, potentially providing better pain relief for low back and leg pain. The study is a randomized, double-blind, sham-controlled crossover trial designed to evaluate how effective burst SCS is for this type of chronic pain. The study involves implanting a device called the ProclaimTM XR implantable pulse generator along with an Octrode4-contact lead under the skin for long-term therapy. Participants will receive burst SCS, which uses complex programming to deliver high-frequency bursts at 40 Hz with spikes at 500 Hz. There is also a sham stimulation condition where no spinal cord stimulation is provided. The trial includes a crossover design, meaning participants will experience both burst stimulation and sham stimulation at different times, without knowing which one they are receiving. Participants will be assessed for changes in their disease-specific functional outcomes over 12 months. Before the trial, they must have a successful two-week testing period with tonic SCS that reduces their leg pain by at least 2 points or 50% on the pain scale. Throughout the study, researchers will monitor pain levels and functional improvements to see how well the burst SCS works compared to no stimulation. The total involvement includes device implantation, stimulation periods, and follow-up evaluations to ensure safety and effectiveness.
CONDITIONS
Official Title
Burst Crossover Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have undergone 1 back surgeries and developed chronic radicular pain that has remained refractory to non-surgical treatment for 6 months
- Minimum pain intensity of 5/10 on the leg pain NRS at baseline
- Successful two-week SCS testing period with tonic stimulation (at least 2 points reduction in leg pain NRS from baseline)
- Mandatory assessment at the Multidisciplinary outpatient clinic for back-, neck- and shoulder rehabilitation, St. Olavs University Hospital
- Successful two-week SCS testing period with tonic stimulation (50% reduction in leg pain NRS from baseline)
You will not qualify if you...
- Coexisting conditions that would increase procedural risk (e.g., sepsis, coagulopathy)
- History of laminectomy or posterior fusion at the thoracolumbar junction where percutaneous electrode end tips are routinely placed
- Abnormal pain behavior and/or unresolved psychiatric illness
- Unresolved issues of secondary gain or inappropriate medication use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St Olavs Hospital
Trondheim, Norway
Actively Recruiting
Research Team
S
Sasha Gulati, md prof
S
Sven M Carlsen, md prof
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here